Now showing items 11-20 of 22
Product Liability in Pharmaceuticals: Comments on Chapters Eight and Nine
(The Liability Maze: The Impact of Liability Law on Safety and Innovation, 1991)
With an ever-increasing number of liability lawsuits, are corporations electing to play it safe rather than risk the uncertainties accompanying innovation? In The Liability Maze experts address the issues surrounding safety ...
The Pharmaceutical Industry
(Government and Technical Progress, 1982)
Encouraging innovative treatment of neglected diseases through priority review vouchers
(Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, 2009-09-01)
Economic Evaluation of Drug Treatment for Psychiatric Disorders: The New Clinical Trial Protocol
(Psychopharmacology: the Fourth Generation of Progress, 1995)
The Changing Economics of Pharmaceutical Research and Development
(The Changing Economics of Medical Technology, 1991-01-01)
Impact of Public Policy on Drug Innovation and Pricing
(Impact of Public Policy on Drug Innovation and Pricing, 1976)
Pressures from the Demand Side: Changing Market Dynamics and Industrial Structure
(Consolidation and Competition in the Pharmaceutical Industry, 2001)
Increasing R&D Incentives for Neglected Diseases: Lessons from the Orphan Drug Act
(International Public Goods And Transfer Of Technology Under A Globalized Intellectual Property Regime, 2005)
Competition between Generic and Branded Drugs
(Pharmaceutical innovation: incentives, competition, and cost-benefit analysis in international perspective, 2007-04-30)
The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being ...
'Price and Profit Control, New Competitive Dynamics and the Economics of Innovation in the Pharmaceutical Industry'
(Industrial Policy and the Pharmaceutical Industry, 1995)